Effect of Smoking Status on Clinical Outcome and Efficacy of Clopidogrel in Acute Coronary Syndrome-Reference-Cited by-同舟云学术

Effect of Smoking Status on Clinical Outcome and Efficacy of Clopidogrel in Acute Coronary Syndrome

Published:2016 Issue:7 Volume:80 Page:1590-1599
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Kodaira Masaki¹,Miyata Hiroaki²,Numasawa Yohei¹,Ueda Ikuko³,Maekawa Yuichiro³,Sueyoshi Koichiro⁴,Ishikawa Shiro⁵,Ohki Takahiro⁶,Negishi Kouji⁷,Fukuda Keiichi³,Kohsaka Shun³

Affiliation:

1. Department of Cardiology, Ashikaga Red Cross Hospital

2. Department Healthcare Quality Assessment, The University of Tokyo

3. Department of Cardiology, Keio University School of Medicine

4. Department of Cardiology, Kawasaki Municipal Hospital

5. Department of Cardiology, Saitama City Hospital

6. Department of Cardiology, Tokyo Dental University

7. Department of Cardiology, Yokohama Municipal Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/80/7/80_CJ-16-0032/_pdf

Reference40 articles.

1. 1. Carter BD, Abnet CC, Feskanich D, Freedman ND, Hartge P, Lewis CE, et al. Smoking and mortality: Beyond established causes. N Engl J Med 2015; 372: 631–640.

2. 2. Barbash GI, White HD, Modan M, Diaz R, Hampton JR, Heikkila J, et al. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation 1993; 87: 53–58.

3. 3. Grines CL, Topol EJ, O’Neill WW, George BS, Kereiakes D, Phillips HR, et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation 1995; 91: 298–303.

4. 4. Gottlieb S, Boyko V, Zahger D, Balkin J, Hod H, Pelled B, et al. Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey). J Am Coll Cardiol 1996; 28: 1506–1513.

5. 5. Angeja BG, Kermgard S, Chen MS, McKay M, Murphy SA, Antman EM, et al. The smoker’s paradox: Insights from the angiographic substudies of the TIMI trials. J Thromb Thrombolysis 2002; 13: 133–139.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between post-stroke smoking and stroke recurrence in first-ever ischemic stroke survivors: based on a 10-year prospective cohort;Neurological Sciences;2023-06-08

2. Smoking and Provision of Smoking Cessation Interventions among Inpatients with Acute Coronary Syndrome in China: Findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project;Global Heart;2020-10-23

3. Influences of Smoking Status on Effectiveness of Cytochrome P450 Enzyme System Metabolized Medications in Reducing In-Hospital Death in 14 658 Patients With Acute Myocardial Infarction: Data From CPACS-3 Study;Journal of Cardiovascular Pharmacology and Therapeutics;2020-04-26

4. Impact of smoking on all-cause mortality and cardiovascular events in patients after coronary revascularization with a percutaneous coronary intervention or coronary artery bypass graft;Coronary Artery Disease;2019-08

5. Effectiveness and Safety of Platelet ADP–P2Y12 Receptor Inhibitors Influenced by Smoking Status: A Systematic Review and Meta‐Analysis;Journal of the American Heart Association;2019-04-02